Blueprint Medicines (BPMC) PT Lowered to $50 at Barclays

January 6, 2023 6:11 AM EST Send to a Friend

Barclays analyst Peter Lawson lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Blueprint Medicines (BPMC) PT Lowered to $50 at Barclays

Member Login

Free News Feed